evidence table

Cissus Joint Stiffness Meta-Analysis Evidence Table

Structured evidence table for Cissus Joint Stiffness Meta-Analysis, generated from 2 reusable source documents in the Migaku knowledge base.

topicclaimevidence levelcitationsource
Cissus Joint Stiffness Meta-AnalysisWorld Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2025).4World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2025). (2025)World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2025).
Cissus Joint Stiffness Meta-AnalysisConclusion Asthiposhak Tablets exhibited significant efficacy in enhancing both BMD (T-score) and Ayurvedic Symptom Score, thereby substantiating their osteoprotective potential in individuals with Asthikshaya (osteopenia).4Kumar K (2023)A Pilot, Open-Label, Proof-of-Concept Study To Evaluate the Efficacy and Safety of Asthiposhak® Tablets in Participants Suffering From Asthikshaya or Osteopenia.
Cissus Joint Stiffness Meta-AnalysisFurthermore, the tablets were found to reduce the levels of biochemical markers, such as serum bone-specific alkaline phosphatase and osteocalcin, suggesting their anti-resorptive action.4Kumar K (2023)A Pilot, Open-Label, Proof-of-Concept Study To Evaluate the Efficacy and Safety of Asthiposhak® Tablets in Participants Suffering From Asthikshaya or Osteopenia.
Cissus Joint Stiffness Meta-AnalysisIntroduction Both osteoporosis and osteopenia are prevalent public health concerns worldwide and can lead to debilitating bone fractures.4Kumar K (2023)A Pilot, Open-Label, Proof-of-Concept Study To Evaluate the Efficacy and Safety of Asthiposhak® Tablets in Participants Suffering From Asthikshaya or Osteopenia.
Cissus Joint Stiffness Meta-AnalysisThis study aimed to assess the efficacy of Asthiposhak® Tablets in individuals with Asthikshaya (osteopenia) by measuring changes in the bone mineral density (BMD) score before and after the intervention, specifically between visit 1 (baseline) and visit 8 (after 180 days of treatment).4Kumar K (2023)A Pilot, Open-Label, Proof-of-Concept Study To Evaluate the Efficacy and Safety of Asthiposhak® Tablets in Participants Suffering From Asthikshaya or Osteopenia.
topicCissus Joint Stiffness Meta-Analysis
claimWorld Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2025).
evidence level4
citationWorld Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2025). (2025)
sourceWorld Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2025).
topicCissus Joint Stiffness Meta-Analysis
claimConclusion Asthiposhak Tablets exhibited significant efficacy in enhancing both BMD (T-score) and Ayurvedic Symptom Score, thereby substantiating their osteoprotective potential in individuals with Asthikshaya (osteopenia).
evidence level4
citationKumar K (2023)
sourceA Pilot, Open-Label, Proof-of-Concept Study To Evaluate the Efficacy and Safety of Asthiposhak® Tablets in Participants Suffering From Asthikshaya or Osteopenia.
topicCissus Joint Stiffness Meta-Analysis
claimFurthermore, the tablets were found to reduce the levels of biochemical markers, such as serum bone-specific alkaline phosphatase and osteocalcin, suggesting their anti-resorptive action.
evidence level4
citationKumar K (2023)
sourceA Pilot, Open-Label, Proof-of-Concept Study To Evaluate the Efficacy and Safety of Asthiposhak® Tablets in Participants Suffering From Asthikshaya or Osteopenia.
topicCissus Joint Stiffness Meta-Analysis
claimIntroduction Both osteoporosis and osteopenia are prevalent public health concerns worldwide and can lead to debilitating bone fractures.
evidence level4
citationKumar K (2023)
sourceA Pilot, Open-Label, Proof-of-Concept Study To Evaluate the Efficacy and Safety of Asthiposhak® Tablets in Participants Suffering From Asthikshaya or Osteopenia.
topicCissus Joint Stiffness Meta-Analysis
claimThis study aimed to assess the efficacy of Asthiposhak® Tablets in individuals with Asthikshaya (osteopenia) by measuring changes in the bone mineral density (BMD) score before and after the intervention, specifically between visit 1 (baseline) and visit 8 (after 180 days of treatment).
evidence level4
citationKumar K (2023)
sourceA Pilot, Open-Label, Proof-of-Concept Study To Evaluate the Efficacy and Safety of Asthiposhak® Tablets in Participants Suffering From Asthikshaya or Osteopenia.

Learn next

Related evidence and supplement guides

SupplementCollagen PeptidesHydrolysed collagen that stimulates fibroblasts — evidence for joints, skin elasticity, and tend...SupplementBerberinePlant alkaloid with clinical evidence rivalling metformin for blood glucose control and lipid ma...GuideCissus Joint Stiffness Meta-analysis: What the Evidence SaysCissus Joint Stiffness Meta-analysis has 2 source documents in the current Migaku evidence datab...GuideGlucosamine Joint Stiffness Meta-analysis: What the Evidence SaysGlucosamine Joint Stiffness Meta-analysis has 2 source documents in the current Migaku evidence...GuideGlucosamine Joint Comfort Meta-analysis: What the Evidence SaysGlucosamine Joint Comfort Meta-analysis has 2 source documents in the current Migaku evidence da...GuideHydrolyzed Collagen Joint Pain Meta-analysis: What the Evidence SaysHydrolyzed Collagen Joint Pain Meta-analysis has 2 source documents in the current Migaku eviden...AnswerDoes Glucosamine Joint Comfort Meta-Analysis work?Glucosamine Joint Comfort Meta-Analysis has evidence relevant to strength of evidence and what t...AnswerIs Glucosamine Joint Comfort Meta-Analysis safe?Glucosamine Joint Comfort Meta-Analysis has evidence relevant to safety, limits, and clinician-d...

Source documents

  1. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2025).
  2. A Pilot, Open-Label, Proof-of-Concept Study To Evaluate the Efficacy and Safety of Asthiposhak® Tablets in Participants Suffering From Asthikshaya or Osteopenia.